Found 392 clinical trials
A 3-week study to evaluate a generic non-steroidal topical cream for the treatment of eczema.
A 3-week study to evaluate a generic non-steroidal topical cream for the treatment of eczema.
- 190 views
- 08 Nov, 2020
- 1 location
A 4-week study to evaluate a generic non-steroidal topical cream for the treatment of eczema.
A 4-week study to evaluate a generic non-steroidal topical cream for the treatment of eczema.
- 109 views
- 08 Nov, 2020
- 1 location
A Washington University research study seeks female participants.
A Washington University research study seeks female participants.
- 160 views
- 25 Mar, 2021
- 1 location
A Study of Bermekimab for the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis
The purpose of this study is to evaluate the efficacy of Bermekimab, compared with placebo, in participants with moderate-to-severe atopic dermatitis (AD).
- 4 views
- 01 Dec, 2021
- 32 locations
A Study of Bermekimab (JNJ-77474462) in the Treatment of Participants With Moderate to Severe Atopic Dermatitis
The purpose of this study is to evaluate the efficacy and safety of bermekimab in participants with moderate to severe atopic dermatitis (AD).
- 41 views
- 02 Dec, 2021
- 54 locations
Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis
Long-Term Safety and Efficacy of Nemolizumab in Subjects with Moderate-to-Severe Atopic Dermatitis Description
- 112 views
- 28 Oct, 2021
- 479 locations
Pharmacokinetics Safety and Efficacy of Nemolizumab in Participants With Moderate-to-Severe Atopic Dermatitis
The purpose of this study is to assess the pharmacokinetics (PK), efficacy, and safety of nemolizumab in pediatric participants with moderate-to-severe atopic dermatitis (AD).
- 0 views
- 18 Oct, 2021
- 30 locations
Study of Subcutaneous Risankizumab Injection Compared to Oral Apremilast Tablets to Assess Change in Disease Activity And Adverse Events in Adult Participants With Moderate Plaque Psoriasis Who Are Candidates for Systemic Therapy
Psoriasis (PsO) is a chronic disease characterized by marked inflammation of the skin that results in thick, red, scaly plaques. This study will assess how safe and effective risankizumab is
- 9 views
- 17 Nov, 2021
- 70 locations
Silverlon to Reduce Radiation Dermatitis
The purpose of this study is to see if a silver-nylon dressing (Silverlon, Argentum Medical) is useful for the prevention or treatment of radiation dermatitis in patients receiving radiation
- 0 views
- 22 Aug, 2021
- 1 location